Although further studies are required to confirm the mode of action of C/EBP-β in the tumor, it is tempting to speculate that LAP or certain LAP-induced genes may serve as potential therapeutic targets for cancer and for other ER stress–mediated diseases. The gene discussed is CEBPB; the disease is cancer.